Nonneovascular age-related macular degeneration

3 papers study it1 finding

Humans3

Associations

1

ABCA1

upin humans1HR 1.26

1 study

ABCA1 raises the risk of nonneovascular age-related macular degeneration in humans (HR 1.26 (95% CI 1.06-1.50)).
“1.26 (1.06-1.50) for nonneovascular AMD”
Humansthird versus first tertile in multivariable adjusted model10 to 18 yearsn = 80,972
Genetic variants in the adenosine triphosphate-binding cassette transporter A1 and risk of age-related macular degeneration
European journal of epidemiologyJun 19, 2023

Latest

1 paper in 12 months

Ophthalmology RetinaNov 7

Glucagon-Like Peptide-1 Receptor Agonist Use and Risk of Neovascular Age-Related Macular Degeneration in a National Cohort Study

Cohort study in peopleNeovascular age-related macular degeneration

Ophthalmology ScienceJan 4

Targeted High-Density Microperimetry Testing of Nascent Geographic Atrophy in Age-Related Macular Degeneration

Cohort study of 176 peopleAge-related macular degeneration

European Journal of EpidemiologyJun 19

Genetic variants in the adenosine triphosphate-binding cassette transporter A1 and risk of age-related macular degeneration

Cohort study of 80,972 peopleNeovascular age-related macular degeneration